168 related articles for article (PubMed ID: 37780210)
1. The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer.
Di Benedetto C; Borini Etichetti C; Cocordano N; Cantoia A; Arel Zalazar E; Bicciato S; Menacho-Márquez M; Rosano GL; Girardini J
Front Mol Biosci; 2023; 10():1145279. PubMed ID: 37780210
[TBL] [Abstract][Full Text] [Related]
2. β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway.
Xiao MB; Jin DD; Jiao YJ; Ni WK; Liu JX; Qu LS; Lu CH; Ni RZ; Jiang F; Chen WC
Mol Biol Rep; 2018 Dec; 45(6):1863-1871. PubMed ID: 30306507
[TBL] [Abstract][Full Text] [Related]
3. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
4. Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.
Liu J; Wen G; Cao D
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):246-53. PubMed ID: 19522700
[TBL] [Abstract][Full Text] [Related]
5. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential.
Khayami R; Hashemi SR; Kerachian MA
J Cell Mol Med; 2020 Aug; 24(16):8890-8902. PubMed ID: 32633024
[TBL] [Abstract][Full Text] [Related]
6. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer.
Hojnik M; Šuster NK; Smrkolj Š; Sisinger D; Grazio SF; Verdenik I; Rižner TL
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159076
[TBL] [Abstract][Full Text] [Related]
7. Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks.
Banerjee S
Adv Exp Med Biol; 2021; 1347():65-82. PubMed ID: 33945128
[TBL] [Abstract][Full Text] [Related]
8. ZNF521/EBF1 axis regulates AKR1B1 to promote the proliferation, migration, and invasion of gastric cancer cells.
Cheng Y; Ni YJ; Tang LM
Kaohsiung J Med Sci; 2023 Mar; 39(3):244-253. PubMed ID: 36397644
[TBL] [Abstract][Full Text] [Related]
9. Aldo-keto reductase family 1 member B induces aortic valve calcification by activating hippo signaling in valvular interstitial cells.
Gao C; Hu W; Liu F; Zeng Z; Zhu Q; Fan J; Chen J; Cheng S; Yu K; Qian Y; Ren T; Zhao J; Liu X; Wang J
J Mol Cell Cardiol; 2021 Jan; 150():54-64. PubMed ID: 33045251
[TBL] [Abstract][Full Text] [Related]
10. [Aldo-keto reductase 1 member B1 (AKR1B1) inhibits retinal ganglion cell activity via activating NF-κB pathway and inducing mouse BV-2 microglia activation].
Bai Q; Wang X; Mao X; Hu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1063-1068. PubMed ID: 33325358
[TBL] [Abstract][Full Text] [Related]
11. The Expression and Clinical Significance of Aldo-Keto Reductase 1 Member B1 in Gastric Carcinoma.
Li X; Yang J; Gu X; Xu J; Li H; Qian J; Chen L
DNA Cell Biol; 2020 Jul; 39(7):1322-1327. PubMed ID: 32412859
[TBL] [Abstract][Full Text] [Related]
12. EPS15-AS1 Inhibits AKR1B1 Expression to Enhance Ferroptosis in Hepatocellular Carcinoma Cells.
Man Q; Zhang G; Chen X; Na SR; Bai S; Zhi H; Sun L; Pang H
J Cancer; 2024; 15(4):1030-1040. PubMed ID: 38230218
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
[TBL] [Abstract][Full Text] [Related]
14. Aldo-keto reductases in the eye.
Huang SP; Palla S; Ruzycki P; Varma RA; Harter T; Reddy GB; Petrash JM
J Ophthalmol; 2010; 2010():521204. PubMed ID: 20628518
[TBL] [Abstract][Full Text] [Related]
15. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.
Wu X; Li X; Fu Q; Cao Q; Chen X; Wang M; Yu J; Long J; Yao J; Liu H; Wang D; Liao R; Dong C
J Exp Med; 2017 Apr; 214(4):1065-1079. PubMed ID: 28270406
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
17. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas.
Hojnik M; Frković Grazio S; Verdenik I; Rižner TL
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298614
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.
Saeed A; Ejaz SA; Sarfraz M; Tamam N; Siddique F; Riaz N; Qais FA; Chtita S; Iqbal J
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807227
[TBL] [Abstract][Full Text] [Related]
19. Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone.
Morikawa Y; Miyazono H; Kamase K; Suenami K; Sasajima Y; Sato K; Endo S; Monguchi Y; Takekoshi Y; Ikari A; Matsunaga T
Neurotox Res; 2021 Aug; 39(4):1360-1371. PubMed ID: 34043181
[TBL] [Abstract][Full Text] [Related]
20. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression.
Chen D; Shen Z; Cheng X; Wang Q; Zhou J; Ren F; Sun Y; Wang H; Huang R
Bioengineered; 2021 Dec; 12(1):1964-1975. PubMed ID: 34027794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
